Elite Pharmaceuticals, Inc. (OTCMKTS:ELTP) Short Interest Update

Elite Pharmaceuticals, Inc. (OTCMKTS:ELTP) saw a significant growth in short interest in August. As of August 31st, there was short interest totalling 1,834,800 shares, a growth of 10.5% from the August 15th total of 1,661,100 shares. Based on an average daily trading volume, of 5,263,800 shares, the short-interest ratio is presently 0.3 days.

Elite Pharmaceuticals Price Performance

ELTP traded down $0.01 on Wednesday, reaching $0.38. The stock had a trading volume of 1,393,660 shares, compared to its average volume of 1,253,772. The company has a current ratio of 3.08, a quick ratio of 2.09 and a debt-to-equity ratio of 0.08. The company has a market capitalization of $408.64 million, a price-to-earnings ratio of 38.25 and a beta of 0.18. Elite Pharmaceuticals has a fifty-two week low of $0.08 and a fifty-two week high of $0.42. The firm has a 50-day moving average of $0.23 and a 200-day moving average of $0.18.

Elite Pharmaceuticals Company Profile

Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.